Pfizer Limited (PFIZER.NS)
Pfizer Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $4874.80, down 2.32% on the session, giving a market capitalisation of $223.01B. Its beta of 0.12 implies it has historically moved less than the broad market.
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
Pfizer Limited is most often compared with the following Healthcare names: